Literature DB >> 28441213

The Role of Denosumab in the Modern Treatment of Giant Cell Tumor of Bone.

Patrick Thornley1, Anthony Habib, Anthony Bozzo, Nathan Evaniew, Michelle Ghert.   

Abstract

Entities:  

Year:  2017        PMID： 28441213     DOI： 10.2106/JBJS.RVW.16.00072

Source DB:  PubMed          Journal:  JBJS Rev        ISSN： 2329-9185


× No keyword cloud information.
  6 in total

Review 1.  Integration of denosumab therapy in the management of giant cell tumors of bone.

Authors:  Daniel T Miles; Ryan T Voskuil; Wood Dale; Joel L Mayerson; Thomas J Scharschmidt
Journal:  J Orthop       Date:  2020-03-28

2.  Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.

Authors:  Manish G Agarwal; Manit K Gundavda; Rajat Gupta; Rajeev Reddy
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

Review 3.  Intrathoracic Extension of a Giant Cell Tumour of the Medial End of Clavicle: A Case Report with Review of Literature.

Authors:  Shaswat Mishra; Manish Jain; Sandeep Gavhale; Sagar Bansal; Sanjeev Ghildiyal; Mitali Mokashi
Journal:  Indian J Orthop       Date:  2022-09-02       Impact factor: 1.033

Review 4.  Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence.

Authors:  Aneta Maria Borkowska; Anna Szumera-Ciećkiewicz; Bartłomiej Szostakowski; Andrzej Pieńkowski; Piotr Lukasz Rutkowski
Journal:  Cancers (Basel)       Date:  2022-05-04       Impact factor: 6.575

5.  A novel subchondral bone-grafting procedure for the treatment of giant-cell tumor around the knee: A retrospective study of 27 cases.

Authors:  Minhao Wu; Shiyi Yao; Yuanlong Xie; Feifei Yan; Zhouming Deng; Jun Lei; Lin Cai
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.

Authors:  Run-Zi Zhang; Tian-Xiao Ma; Dian-Wen Qi; Ming Zhao; Tongyu Hu; Guo-Chuan Zhang
Journal:  Orthop Surg       Date:  2019-11-25       Impact factor: 2.071
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.